Bookmark and Share

Last Minute:          For more news, click here.

Authentication
       
       
Remember me? 

Rise of
+0.43 (+1.01%) Abbott Laboratori - [Ticker: ABT]Chart Abbott Laboratori  News Abbott Laboratori  Download Historical Prices for Metastock Abbott Laboratori and Others  Technical Analysis Abbott Laboratori  
Last Trade73.26Last Trade Time2018-11-29 - 00:00:00
Variation+0.43 (+1.01%)Open72.43
High73.70Low72.37
Volume6,399,884Average Volume (3m)0
YieldBid / Ask54.24 x 1,400 - 54.25 x 400
Former Close72.8352 Week Range[0.00 - 0.00]
PER0.00%EPS0.00
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Abbott Laboratori -  [Ticker: ABT] chart
Change to Abbott Laboratori Interactive Technical Analysis Chart

Last 10 Forum Topics about Abbott Laboratori:
No topics about Abbott Laboratori [ABT] have been found, but a search on the Forum for more topics related to Abbott Laboratori is advised.

 News about Abbott Laboratori [ABT]:   (ordered by relevance)
  1. Abbott Laboratories: A Lesser Johnson & Johnson? (NYSE:ABT)  Seeking Alpha
  2. Abbott (ABT) Stock: $132 Target And Outperform Rating  Pulse 2.0
  3. Abbott Laboratories (NYSE:ABT) Lifted to ?Strong-Buy? at StockNews.com  Defense World
  4. If You Invested $25,000 in Abbott Laboratories in 2013, This Is How Much You Would Have Today  The Motley Fool
  5. Abbott Laboratories stock outperforms competitors despite losses on the day  MarketWatch
  1. Abbott Laboratories (ABT) Q2 2022 Earnings Call Transcript  The Motley Fool
  2. Abbott Posts Beastly Covid Testing Growth ? But It's Not Sustainable  Investor's Business Daily
  3. Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance  PR Newswire
  4. Abbott Laboratories (ABT) CEO Robert Ford on Q2 2022 Results - Earnings Call Transcript  Seeking Alpha
  5. Abbott aims to recapture baby formula market share  Reuters.com
Will Abbott Stock Rise After Its Q2 Results?  Forbes ABT: Is Abbott Labs A "Strong Buy" After Earnings?  StockNews.com Abbott Reopens Michigan Baby Formula Plant After Flooding Shutdown  Bloomberg Is Abbott Laboratories Stock A Sell Before Upcoming Earnings? (NYSE:ABT)  Seeking Alpha ABT: Is Abbott Stock a Buy at $105 as Production in Troubled Plant Resumes?  StockNews.com Big Tech off the hook; Abbott under fire; Musk-Twitter feud: 3 legal stories to watch  Yahoo Canada Finance Abbott and WeightWatchers Partner to Support People Living with Diabetes in Attaining their Health Goals  PR Newswire Abbott Labs Stock Can Be a Recession Hedge for Your Portfolio  Entrepreneur ABT: 2 Medical Stocks That Are Attractive Buys Right Now  StockNews.com Abbott's deep brain stimulation device gains Breakthrough Therapy status for depression  Seeking Alpha Existing Home Sales, Tesla, Abbott Labs: 3 Things to Watch By Investing.com  Investing.com Should You Really Care About This Company's Short-Term Success?  The Motley Fool ABBOTT ALERT: Bragar Eagel & Squire, P.C. is Investigating Abbott Laboratories on Behalf of Abbott Stockholders and Encourages Investors to Contact the Firm  Business Wire This Is What Whales Are Betting On Abbott Laboratories  Benzinga ABT: 5 Stocks With the Most Long-Term Growth Potential  StockNews.com Abbott: FDA Grants Breakthrough Device Designation To Investigate DBS System In TRD  Nasdaq Catalyst Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors  MarketWatch The Math Behind GE's Breakup. It's a Sum-of-the-Parts Party.  Barron's Baby Formula Shortage Tests Outlook for Manufacturers  Morningstar DexCom Inc. stock rises Monday, outperforms market  MarketWatch 3 Dividend Aristocrats to Buy in August  The Motley Fool Abbott (ABT) Formula: FDA Investigating Another Infant Death  Bloomberg Millions of Americans Could Soon Face an Additional $393 Monthly Payment  TheStreet Medtronic PLC stock rises Monday, outperforms market  MarketWatch Abbott in Pact With FDA on Steps to Reopen Baby-Formula Plant  Bloomberg Baby Formula Shortage: Abbott (ABT) Factory Bacteria Risk Spotted Last Year  Bloomberg Abbott Laboratories (ABT) Q1 2022 Earnings Call Transcript  The Motley Fool 2 Healthcare Stocks That Could Benefit From This Growing Market  Investing.com The 3 Best Vanguard Funds to Buy in August  InvestorPlace Hologic Inc. stock outperforms market on strong trading day  MarketWatch Should You Buy Abbott Stock At $110?  Forbes Baby Formula Shortage: Abbott (ABT) Tax Practices Under Investigation by Senator  Bloomberg Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson  Investing News Network Abbott Stock (ABT): Q1 2022 Earnings Indicate A Solid Conviction Pick  Seeking Alpha Here's Why You Should Invest in Abbott (ABT) Stock Right Now  Nasdaq Abbott Plans to Launch Health Wearables Outside the U.S. Later This Year  Bloomberg Abbott (ABT) FreeStyle Libre 3 System's Study Outcome Favorable  Nasdaq Abbott's Covid Testing Sales Rival Those of Late 2020  Bloomberg Vertex: Q2 2022 Earnings Steady - But Expect Volatility Soon (NASDAQ:VRTX)  Seeking Alpha Abbott Announces Future of Biowearables at Consumer Electronics Show  PR Newswire Here's A Better Pick Over Abbott Stock  Forbes This Medical Devices Company Is A Better Pick Over Abbott Stock  Forbes Abbott: Closing The Gap On Industry Leader (NYSE:ABT)  Seeking Alpha Abbott says monkeypox test is currently under development (NYSE:ABT)  Seeking Alpha ABT: Abbott Laboratories vs. Edwards Lifesciences: Which Medical Device Stock is a Better Investment?  StockNews.com Why Investors Should Focus on Abbott's Medical Devices  The Motley Fool Abbott Stock Closes On Key Benchmark  Investor's Business Daily Should You Buy Abbott Stock After Its Recent Fall?  Forbes This Healthcare Company Is A Better Pick Over Abbott Stock  Forbes (ABT Alert) Long Term Holders of Abbott Laboratories Contact Johnson Fistel for Information Regarding Investigation  GlobeNewswire Abbott Stock is an Oversold Play  Entrepreneur Abbott Stock: Back Where We Were 12 Months Ago Is Not A Bad Place To Be (NYSE:ABT)  Seeking Alpha Here's Why You Should Retain Abbott (ABT) Stock For Now  Nasdaq Abbott Voluntarily Recalls Powder Formulas Manufactured at One Plant  FDA.gov Abbott contaminated-baby-formula probe faces uncertainty - WSJ (NYSE:ABT)  Seeking Alpha 2 Green Flags for Abbott Laboratories' Future  The Motley Fool Abbott Recommends Rejection of Below-Market Mini-Tender Offer by TRC Capital Investment Corporation  PR Newswire Abbott Laboratories: Why this stock is a smart buy  USA TODAY Abbott Laboratories Can be a Port in the Market Storm  Entrepreneur Abbott Laboratories (ABT) CEO Robert Ford Presents at JPMorgan 40th Annual Healthcare Brokers Conference (Transcript)  Seeking Alpha Abbott Laboratories Non-GAAP EPS of $1.73 beats by $0.27, revenue of $11.9B beats by $900M (NYSE:ABT)  Seeking Alpha SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abbott Laboratories - ABT  PR Newswire Will Abbott Laboratories Be a Trillion-Dollar Stock by 2035?  The Motley Fool Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise  PR Newswire FDA probe of Abbott facility finds quality control issues  Reuters.com ABBOTT LABORATORIES INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Continues to Investigate Abbott Laboratories' Directors and Officers for Breach of Fiduciary Duties ? ABT  Business Wire 3 Things About Abbott Laboratories That Smart Investors Know  The Motley Fool Abbott announces FDA clearance for FreeStyle Libre 3 glucose monitor (NYSE:ABT)  Seeking Alpha Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes  PR Newswire A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)  Yahoo Eurosport UK Abbott - baby formula FDA inspection to undergo HHS review (NYSE:ABT)  Seeking Alpha Abbott Declares 394th Consecutive Quarterly Dividend - Jun 10, 2022  Press Releases Abbott profit, sales beat estimates on vigorous COVID test demand  Reuters.com Abbott Falls After Cutting 2021 Profit Forecast as Testing Slows  Bloomberg Abbott Laboratories (NYSE:ABT) Has A Rock Solid Balance Sheet  Simply Wall St Abbott Laboratories raises quarterly dividend by ~4%, $5B authorized in share repurchase  Seeking Alpha Abbott: Great Company, But Stock Price Makes It Unattractive  Seeking Alpha Abbott Laboratories (ABT) Company Profile, News, Rankings | Fortune  Fortune What Could the Baby Formula Shortage Mean for Abbott Laboratories?  The Motley Fool Here's Why Abbott's a Great Buy Even if COVID Testing Revenue Falls  The Motley Fool Baby-Formula Shortage Spurs US to Prod Abbott Over Access  Bloomberg Top Stock Reports for Abbott Laboratories, T-Mobile & Intuit  Yahoo Finance Abbott to release some nutrition products halted after baby formula recall  Reuters.com Baby formula shortage could ease as Abbott reopens Michigan plant  Reuters.com Abbott (ABT) Introduces New Next-Generation Infant Formula  Nasdaq INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Abbott Laboratories' Directors and Officers for Breach of Fiduciary Duties ? ABT  GlobeNewswire Finally, a Reasonable Price For This Healthcare Blue Chip  The Motley Fool ABBOTT LABORATORIES INVESTIGATION REMINDER: Scott+Scott Attorneys at Law LLP Continues to Investigate Abbott Laboratories' Directors and Officers for Breach of Fiduciary Duties ? ABT  GlobeNewswire Scott+Scott Attorneys at Law LLP Continues to Investigate Abbott Laboratories' Directors and Officers for Breach of Fiduciary Duties ? ABT  GlobeNewswire Does Abbott's Baby Formula Issue Present an Opportunity for Reckitt Benckiser?  TipRanks With Covid-19 Cases Falling Again Will Abbott Stock See Higher Levels?  Forbes Abbott halts EleCare output from plant at center of baby formula shortage  Reuters Better Dividend King: Johnson & Johnson vs. Abbott Laboratories  The Motley Fool New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies  PR Newswire Abbott Labs is Set to Outperform the Market. Here's Why.  Nasdaq Here's Why This Dividend King Is a Buy for Income Investors  The Motley Fool Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months  PR Newswire Abbott Laboratories (ABT) Q3 2021 Earnings: Key financials and quarterly highlights  AlphaStreet
For more news about Abbott Laboratori click here:
Abbott Laboratori News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 - TR4DER.com, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources